Turning the page: Projections for cancer care in the coming year

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As 2024 approaches, it’s anyone’s guess whether an already complex health care ecosystem gets to turn the corner on the mixed legacies of 2023—including record high prices on new blockbuster medications coupled with drug shortages on existing generics, persistent staff shortages and battered hospital margins, and a continued emphasis on value-based care programs by insurers. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Samyukta Mullangi, MD, MBA
Medical oncologist, Tennessee Oncology; Medical director, Thyme Care
Table of Contents

YOU MAY BE INTERESTED IN

The President’s Cancer Panel released a report, Enhancing Patient Navigation with Technology to Improve Equity in Cancer Care, as part of a White House event acknowledging advancements in navigation support for cancer patients over the past year. The report calls on healthcare organizations, policymakers, and technology developers to keep pace with the rapid advancement and adoption of new technology.

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

Samyukta Mullangi, MD, MBA
Medical oncologist, Tennessee Oncology; Medical director, Thyme Care

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login